BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34907091)

  • 1. BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature.
    Landry AP; Wang JZ; Nassiri F; Patil V; Gao A; Zadeh G
    J Clin Pathol; 2023 May; 76(5):315-319. PubMed ID: 34907091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
    Shankar GM; Abedalthagafi M; Vaubel RA; Merrill PH; Nayyar N; Gill CM; Brewster R; Bi WL; Agarwalla PK; Thorner AR; Reardon DA; Al-Mefty O; Wen PY; Alexander BM; van Hummelen P; Batchelor TT; Ligon KL; Ligon AH; Meyerson M; Dunn IF; Beroukhim R; Louis DN; Perry A; Carter SL; Giannini C; Curry WT; Cahill DP; Barker FG; Brastianos PK; Santagata S
    Neuro Oncol; 2017 Apr; 19(4):535-545. PubMed ID: 28170043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 mutations in high-grade meningioma: implications for patient care.
    Shankar GM; Santagata S
    Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case.
    Ravanpay AC; Barkley A; White-Dzuro GA; Cimino PJ; Gonzalez-Cuyar LF; Lockwood C; Halasz LM; Hisama FM; Ferreira M
    World Neurosurg; 2018 Nov; 119():402-415. PubMed ID: 29981911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline BAP1 Mutation in a Family With Multi-Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review.
    Prasad RN; Gardner UG; Yaney A; Prevedello DM; Koboldt DC; Thomas DL; Mardis ER; Palmer JD
    Front Oncol; 2021; 11():721712. PubMed ID: 34504799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
    Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FNA of Meningioma with Rhabdoid Features Presenting as a Lateral Neck Mass.
    Trabzonlu L; Martinez-Lage M; Deschler D; Paly JJ; Faquin WC
    Head Neck Pathol; 2024 Apr; 18(1):32. PubMed ID: 38658429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Melanoma of the Leptomeninges with BAP1 Expression-Loss in the Setting of a Nevus of Ota: A Clinical, Morphological and Genetic Study of 2 Cases.
    Goldman-Lévy G; Rigau V; Bléchet C; Bens G; Muckensturm B; Delage M; Labrousse F; Haddad V; Attignon V; Pissaloux D; de la Fouchardière A
    Brain Pathol; 2016 Jul; 26(4):547-50. PubMed ID: 26834043
    [No Abstract]   [Full Text] [Related]  

  • 13. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningioma: A Pathology Perspective.
    Toland A; Huntoon K; Dahiya SM
    Neurosurgery; 2021 Jun; 89(1):11-21. PubMed ID: 33588439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 Missense Mutations in Cancer: Friend or Foe?
    Okonska A; Felley-Bosco E
    Trends Cancer; 2019 Nov; 5(11):659-662. PubMed ID: 31735283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
    Leblay N; Leprêtre F; Le Stang N; Gautier-Stein A; Villeneuve L; Isaac S; Maillet D; Galateau-Sallé F; Villenet C; Sebda S; Goracci A; Byrnes G; McKay JD; Figeac M; Glehen O; Gilly FN; Foll M; Fernandez-Cuesta L; Brevet M
    J Thorac Oncol; 2017 Apr; 12(4):724-733. PubMed ID: 28034829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors.
    Ruzevick J; Gibson A; Tatman P; Emerson S; Ferreira M
    J Clin Neurosci; 2021 Sep; 91():105-109. PubMed ID: 34373013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
    de la Fouchardière A; Cabaret O; Savin L; Combemale P; Schvartz H; Penet C; Bonadona V; Soufir N; Bressac-de Paillerets B
    Clin Genet; 2015 Sep; 88(3):273-7. PubMed ID: 25080371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.